A study published in the Nature journal reveals that researchers have discovered that delta inhibitors contained in a new pill may be effective against breast, skin, lung, and pancreatic cancers.

The drug reportedly initially performed well in use by leukemia patients, so much so that it was given to even the patients who were taking placebo pills for the testing.

The study finds that the 'p100delta' enzyme produced by cancer patients that weakens the immune system is slowed down by the delta inhibitor, allowing the body to attack the cancer cells.

The new pill also apparently boosts the body's cancer immunity, allowing the body to fight off the cancer completely.

The medication was tested with mice, but researchers say they are confident that the discovery will be successful with humans.

The United States Food and Drug Administration has granted "Breakthrough Therapy" status to the drugs.

They could be available within a few years.



(Photo: Joe Raedle)